Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEDIRA Study
PACTR202109545700165Phase 4Recruiting
- Sponsor
- Children's Investment Fund Foundation
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Children's Investment Fund Foundation. Primary endpoints: Increased uptake of HIV PrEP and Family Planning at the Post Abortive Care sites, Continuation of PrEP and Family Planning and 1 more. Started Sep 2021; status: recruiting.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202109545700165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202109545700165.